Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

26,820 signal articles · 35 in last 24h · 129,053 total before filter · latest 44m ago
35last 24h
1295last 7d
202● bullish (7d)
131● bearish (7d)
206publishers
AllMacro290Earnings510M&A88Regulatory20Product12Analyst17
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
3 Profitable Stocks with Questionable Fundamentals
StockStory19d agoneutral
3 Profitable Stocks with Questionable Fundamentals

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

RocketLab Rises on Space Interest; Moderna Moves on Flu Shot | Stock Movers
Bloomberg19d agoneutralVIDEO
RocketLab Rises on Space Interest; Moderna Moves on Flu Shot | Stock Movers

On this episode of Stock Movers: - RocketLab (RKLB) shares are higher this morning after rising Friday, following earnings from SpaceX last week. - Moderna (MRNA) shares are moving after last week's news that its mRNA flu shot won US approval in an FDA turnaround. - Intel (INTC) shares are moving after the company said it will be offering $15 billion in common stock, taking advantage of renewed interest in its business prospects during the artificial intelligence data center boom.

Coca-Cola (KO) Stock Looks Near Fair Value While Earnings Sit Above Fair Value
Simply Wall St.19d agoneutral
Coca-Cola (KO) Stock Looks Near Fair Value While Earnings Sit Above Fair Value

Coca-Cola stock has delivered a 75.6% total return over the past 5 years, yet current valuation checks suggest it no longer looks like a clear bargain. The latest Discounted Cash Flow (DCF) intrinsic value estimate sits close to the share price, while the broader metrics lean slightly expensive. Coca-Cola has returned 75.6% over 5 years, which puts extra focus on whether today’s price already reflects investors’ optimism. The company’s role as a long term holding for large institutional...

Vertex Pharmaceuticals (VRTX) Is Up 5.4% After Raising 2026 Revenue Guidance And Expanding Its Pipeline - Has The Bull Case Changed?
Simply Wall St.19d agoneutral
Vertex Pharmaceuticals (VRTX) Is Up 5.4% After Raising 2026 Revenue Guidance And Expanding Its Pipeline - Has The Bull Case Changed?

Vertex Pharmaceuticals recently reported second-quarter 2026 results, with revenue rising to US$3,333.9 million and net income reaching US$1,099.8 million, and raised its full-year 2026 revenue guidance to US$13.10–US$13.20 billion. At the same time, a new collaboration with AbCellera on multispecific T‑cell engagers and a setback for a key cystic fibrosis competitor together highlight Vertex’s efforts to broaden its pipeline while easing pressure on its core franchise. We’ll now examine how...

Microsoft (MSFT) Stock Looks Fully Valued Despite Strong AI Optimism
Simply Wall St.19d agoneutral
Microsoft (MSFT) Stock Looks Fully Valued Despite Strong AI Optimism

Microsoft stock has delivered a 76.8% return over the past 5 years, yet the latest valuation checks suggest it no longer looks obviously cheap, with an intrinsic value estimate from a Discounted Cash Flow (DCF) model that sits close to the current share price and mixed signals from other metrics. After a sharp move in the tech sector and fresh optimism around Microsoft’s cloud and AI businesses, investors are weighing that strong track record against a relatively low overall value score. A...

Cerebras Systems (CBRS) Partners With Lovable, Is The Stock Still A Bargain?
Simply Wall St.19d agoneutral
Cerebras Systems (CBRS) Partners With Lovable, Is The Stock Still A Bargain?

Cerebras Systems (CBRS) is back in focus after announcing a partnership with Lovable to power its software creation platform using Cerebras hardware tailored for low latency AI inference. See our latest analysis for Cerebras Systems. The partnership news landed alongside a sharp 1-day share price return of 7.30%, yet Cerebras Systems still has a year to date share price return that is down 27.11%. Together with earlier data center agreements, the recent 30-day share price return of 5.42%...

2 Services Stocks for Long-Term Investors and 1 We Find Risky
StockStory19d agoneutral
2 Services Stocks for Long-Term Investors and 1 We Find Risky

Business services providers use their specialized expertise to help enterprises streamline operations and cut costs. Furthermore, the demand for their offerings is rising as more clients outsource non-core functions, a trend that has enabled the industry to return 16.8% over the past six months. At the same time, the S&P 500 was up 10.9%.

SpaceX Stock Touches IPO Price
Investopedia19d agoneutral
SpaceX Stock Touches IPO Price

Shares of SpaceX on Monday rose above $135, the price at which the company sold shares to the public in mid-June, for the first time since July 16.